PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.\', \'World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation, Education City, Doha, Qatar.\', \'Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA.\', \'Genomics Laboratory, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.\', \'Department of Genetic Medicine, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.\', \'Department of Mathematics, Statistics, and Physics, Qatar University, Doha, Qatar.\', \'Hamad Medical Corporation, Doha, Qatar.\', \'College of Health Sciences, QU Health, Qatar University, Doha, Qatar.\', \'Biomedical Research Center, Qatar University, Doha, Qatar.\', \'Department of Biomedical Science, College of Health Sciences, Member of QU Health, Qatar University, Doha, Qatar.\', \'Primary Health Care Corporation, Doha, Qatar.\', \'Ministry of Public Health, Doha, Qatar.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/cid/ciaa1846
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 33315061
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all